Publicaciones en colaboración con investigadores/as de University of Texas Health Science Center at San Antonio (34)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 3, pp. 950-960

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic

    Stroke and Vascular Neurology, Vol. 6, Núm. 4, pp. 542-552

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Melatonin as an antitumor agent against liver cancer: An updated systematic review

    Antioxidants, Vol. 10, Núm. 1, pp. 1-27

2020

  1. The urgent need for integrated science to fight COVID-19 pandemic and beyond

    Journal of Translational Medicine, Vol. 18, Núm. 1

2019

  1. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

    The Lancet, Vol. 393, Núm. 10175, pp. 1021-1032

2018

  1. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

  2. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 10, pp. 595-598

2017

  1. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Nature Genetics, Vol. 49, Núm. 9, pp. 1373-1384

2015

  1. Melatonin and endoplasmic reticulum stress: Relation to autophagy and apoptosis

    Journal of Pineal Research, Vol. 59, Núm. 3, pp. 292-307

2014

  1. Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease

    Odontology, Vol. 102, Núm. 2, pp. 290-296

2012

  1. Microwave and magnetic (M2) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis

    Electrophoresis, Vol. 33, Núm. 24, pp. 3810-3819

  2. Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

    Journal of Clinical Oncology, Vol. 30, Núm. 6, pp. 631-636

2011

  1. Role of superoxide-nitric oxide interactions in the accelerated age-related loss of muscle mass in mice lacking Cu, Zn superoxide dismutase

    Aging Cell, Vol. 10, Núm. 5, pp. 749-760

2010

  1. Morbidity in 303 first-episode bipolar I disorder patients

    Bipolar Disorders, Vol. 12, Núm. 3, pp. 264-270

2006

  1. Genetic modification of the manganese superoxide dismutase/glutathione peroxidase 1 pathway influences intracellular ROS generation in quiescent, but not contracting, skeletal muscle cells

    Free Radical Biology and Medicine, Vol. 41, Núm. 11, pp. 1719-1725

  2. Inhibition of neuronal nitric oxide synthase activity by N 1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin

    Journal of Neurochemistry, Vol. 98, Núm. 6, pp. 2023-2033